Angela, welcome to the program
The exact mechanism, which means current management strategies are symptom-based rather than targeted
Wolters Kluwer Clinical Drug Information
While our study was observational and does not definitively confirm an association between GLP-1 medications and reduced breast cancer incidence, it does add to the growing body of evidence suggesting that its worth investigating these weight-loss drugs as potential cancer prevention tools, said Elizabeth McDonald, MD, PhD, professor of radiology at Penn Medicine and lead investigator of the study
Melanotan 1 (afamelanotide) is a linear peptide analogue of alpha-MSH, whereas Melanotan 2 is a cyclic heptapeptide
In the SURMOUNT-1 clinical trial, participants taking 5mg of tirzepatide achieved an average weight reduction of 15% over 72 weeks